Wuhan Baideruikang Biotechnology Co., Ltd.

Wuhan Baideruikang Biotechnology Co., Ltd. was founded in July 2013, located in Wuhan National Bioindustry Base—East Lake Optics Valley Biopolis—Biomedical Accelerator Zone C; it is a high-tech enterprise specializing in the R&D, production, and sales of clinical diagnostic reagent products.

The company has established a complete diagnostic reagent technology development platform and formula optimization system. Many reagent R&D achievements have filled domestic gaps. It possesses core technology for providing NADH and NAD+ stability. The stability indicators of the developed enzymatic diagnostic reagents are significantly better than similar domestic brand reagents. Latex immunoturbidimetry reagents have taken the lead in solving the domestic challenge of serum rheumatoid factor (RF) and heterophile antibody interference in similar reagents. The company is committed to integrating global high-quality diagnostic technology resources, striving to build a top-tier biochemical diagnostic reagent brand, and providing customers with high-quality, cost-effective products.

Currently developed diagnostic varieties involve liver and kidney function tests, carbohydrate metabolism, blood lipid and cardiovascular disease tests, myocardial enzyme spectrum, acute pancreatitis testing, gastritis and gastric cancer screening, rheumatic immune system tests, acute infection rapid tests, etc. The company has rich project experience and supplier resources, a professional sales team, timely and professional after-sales support, and an increasingly complete localized after-sales service network. Baideruikang Biotechnology, with "integrity, pragmatism, pursuit of excellence," creates optimal cost-effective products. With quality first, customer supreme, and sincere service as its purpose, it will continue to launch diagnostic products and equipment with higher technological content, create greater value for customers, and provide better services for public health!